Dr. Daniel S. Berman[email protected]Nuclear MedicineScreening for CAD in diabetics: Which patient? Which test?Screening for coronary artery disease (CAD) in any population is controversial. In this editorial opinion, Dr. Daniel Berman of Cedars-Sinai Medical Center points out what he believes are shortcomings in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study published this week in the Journal of the American Medical Association.April 16, 2009Page 1 of 1Top StoriesMRI5 factors that led to California workplace MRI accidentWhat happened at the Redwood City hospital in California in 2023.BreastNME breast lesions have high malignancy rate on MRI-guided biopsyWomens ImagingMany women interested in AI-based risk assessment for breast cancerCTCT 5-star quality rating system supports optimizationSponsor ContentNominations Are Open — 2026 Minnies
